NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Validation and comparison of tumor-associated trypsin inhibitor (TATI) immunoassays.

Author(s): Janeiro E, Guimarães J, Stenman UH, Catarino M, Itkonen O

Publication: Clin Chim Acta, 2012, Vol. 413, Page 1244-8

PubMed ID: 22507084 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of patient age and gender, fasting prior to collection, collection tube type, storage, freeze-thaw cycling, and quantification platform on levels of tumor-associated trypsin inhibitor (TATI) in serum.

Conclusion of Paper

Patient age significantly affected serum TATI levels in specimens from both men and women, and levels were higher in 18-30 year old women than men in the same age range. Fasting prior to blood draw and collection tube type did not affect TATI levels, and levels were not different between lithium-heparin plasma and serum. The authors report declines in serum TATI concentrations after storage at 4, -20 or -80 degrees C or after 4 freeze-thaw cycles compared to initial levels measured in fresh specimens. The median measured TATI concentrations differed significantly between radioimmunoassay (RIA), time-resolved immunofluorometric assay (TR-IFMA) and enzyme-linked immunosorbent assay (ELISA), and the intra-assay coefficient of variance (CV) and recovery of TATI in spiked plasma depended on technology platform.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of patient age and gender, fasting prior to collection, collection tube type, storage, freeze-thaw cycling, and quantification platform on TATI concentrations in serum and the effects of collecting lithium-heparin plasma instead of serum on TATI levels. To determine the effect of long-term storage, TATI levels in 152 specimens stored at -70 degrees C for 9-11 years were compared to levels in 15 fresh specimens. For the freeze-thaw experiment no details of storage duration or thaw temperature or duration were included.

    Summary of Findings:

    TATI levels were significantly lower in specimens from women aged 31-50 years than those from 18-30 year old women (p=0.0115). In both men and women, TATI was higher serum from individuals over 70 years old than in serum from 51-70 year old patients (p=0.0005 and p=0.0001, respectively). Serum TATI levels were higher in specimens from 18-30 year old women than those from men of the same age (p<0.0001), but no other gender differences were observed. Fasting prior to blood draw, collecting lithium-heparin plasma rather than serum, and serum tube type had no effects on TATI concentrations. The authors report that when serum was stored for 4 weeks at 4 or 20 degrees C, TATI concentrations decreased from initial levels by 15.9% and 19.9%, respectively, but the authors did not note any differences observed at other timepoints. Similarly, the authors report that after 8 weeks at -80 degrees C, TATI concentrations decreased by 19% from initial levels, but they do not discuss other timepoints. Further, the authors report a 19.2% decline in TATI levels after serum was subjected to 4 freeze-thaw cycles at -20 degrees C. Specimens stored for 9-11 years at -70 degrees C had a mean TATI concentration that was 18% lower than the mean level in fresh specimens. The median TATI concentrations were 11.0, 13.5, and 16.0 ug/L using the RIA, IFMA and ELISA, respectively (p<0.0001, all). The intra-assay CVs using ELISA and IFMA were 7.1% and 9.7%, respectively, at 9.5 ug/L and 9.1% and 3.5%, respectively, at 18.8 ug/L. Further, recovery of TATI from spiked serum was less than 87.7-98.7% using IFMA, but 100-117% using ELISA.

    Biospecimens
    Preservative Types
    • None (Fresh)
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein ELISA
    Protein Radioimmunoassay
    Protein Immunoassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Patient gender Female
    Male
    Preaquisition Patient age 18-30 years
    31-50 years
    51-70 years
    >70 years
    Biospecimen Acquisition Type of collection container/solution Glass tube
    Clotting catalyzator tube
    SST II advance tube
    Lithium-heparin tube
    Biospecimen Acquisition Time of biospecimen collection Before eating
    After Finish breakfast
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Biospecimen Preservation Type of fixation/preservation Frozen
    None (fresh)
    Storage Storage temperature 4 degrees C
    -20 degrees C
    -70 degrees C
    -80 degrees C
    Storage Storage duration 0 days
    1 week
    2 weeks
    4 weeks
    8 weeks
    9-11 years
    Immunoassay Specific Technology platform TR-IFMA
    ELISA
    RIA

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...